Factor II G20210A and Factor V G1691A Gene Mutations and Peripheral Arterial Occlusive Disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Thrombosis and Haemostasis

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0037-1613750PMID 10669148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 20210 G to A Prothrombin Polymorphism and Late Complications in Type 1 Diabetes Mellitus

  1999cited by this paper
• The Prevalence of the Prothrombin 20210 G →A Mutation Is not Increased in Angiographically Confirmed Coronary Artery Disease

  1999cited by this paper
• The Factor II G20210A and Factor V G1691A Gene Transitions and Coronary Heart Disease

  1999influential reference
• Activated protein C resistance in patients with peripheral vascular disease.

  1998cited by this paper
• Risk of Myocardial Infarction Associated With Factor V Leiden or Prothrombin Interaction of Coagulation Defects and Cardiovascular Risk Factors : Increased

  1998cited by this paper
• Diagnosis and treatment of chronic lower extremity ischemia

  1998cited by this paper
• Geographic Distribution of the 20210 G to A Prothrombin Variant

  1998cited by this paper
• No Association between the 20210 G/A Prothrombin Gene Mutation and Premature Coronary Artery Disease

  1998cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Prevalence of the prothrombin gene variant 20210 G --> A among patients with myocardial infarction.

  1998cited by this paper
• A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.

  1997cited by this paper
• Should Patients With Atherosclerosis or Peripheral Vascular Disease Be Stratified for Factor V Leiden?

  1997cited by this paper
• Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.

  1997cited by this paper
• The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease

  1997cited by this paper
• Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease.

  1997cited by this paper
• Activated Protein C Resistance, Factor V Leiden and Peripheral Vascular Disease

  1997cited by this paper
• Should patients with atherosclerosis or peripheral vascular disease be stratified for factor V Leiden?

  1997cited by this paper
• Resistance to activated protein C (APC): mutation at ARG506 of coagulation factor V and vascular access thrombosis in haemodialysis patients

  1996cited by this paper
• A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

  1996cited by this paper
• Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries

  1996cited by this paper
• Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.

  1996cited by this paper
• Molecular Cardiovascular Medicine

  1996cited by this paper
• Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease.

  1995cited by this paper
• Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.

  1995influential reference
• Evidence against heterozygous coagulation factor V 1691 G→A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction

  1995cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

  1993cited by this paper

• Asociación entre factores de riesgo, polimorfismos genéticos y ancestría con enfermedad arterial periférica en el Departamento del Cauca-Colombia [Recurso electrónico]

  2019cites this paper
• Genetics in Peripheral Artery Disease

  2018cites this paper
• Brachial artery thrombosis mimicking De Quervain's syndrome: a case report.

  2017cites this paper
• Correlation of the Wells and Simplified Revised Geneva Scores with CT Pulmonary Artery Obstruction Index in Pulmonary Embolism

  2017cites this paper
• Prothrombin G 20210 A mutation and lower extremity peripheral arterial disease : a systematic review and meta-analysis

  2017cites this paper
• Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead

  2017cites this paper
• Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis.

  2015cites this paper
• ULOGA GENSKOG POLIMORFIZMA U NASTANKU TROMBOZE

  2015cites this paper
• Computed Tomography Pulmonary Angiography for Evaluation of Patients With Suspected Pulmonary Embolism: Use or Overuse

  2015cites this paper
• Influence of genetic and environmental factors in peripheral arterial disease natural history: Analysis from six years follow up

  2012cites this paper
• Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm

  2012cites this paper
• Thrombophilic risk factors and peripheral arterial disease severity

  2010cites this paper
• Peripheral Artery Disease and Genetics: Is There a Cause-and-Effect Relationship?

  2010cites this paper
• The fibrinogen gamma 10034C>T polymorphism is not associated with Peripheral Arterial Disease.

  2010cites this paper
• G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease.

  2009cites this paper
• Arteriyel trombozlarda faktör V (G1691A), metilentetrahidrofolat redüktaz (C677T) ve protrombin (G20210A) gen mutasyon sıklığı

  2009cites this paper
• Laboratory evaluation of hypercoagulability with venous or arterial thrombosis.

  2009cites this paper
• The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.

  2009cites this paper
• Floating, non-occlusive, mobile aortic thrombus and splenic infarction associated with protein C deficiency.

  2009cites this paper
• A field synopsis and meta-analysis of genetic association studies in peripheral arterial disease: The CUMAGAS-PAD database.

  2009influential citation
• [Thrombophilias and peripheral arterial occlusive disease].

  2008cites this paper
• Thrombophilia and peripheral arterial disease. Authors reply

  2008cites this paper
• Thrombophilies et artériopathie oblitérante des membres inférieurs

  2008cites this paper
• Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology.

  2007cites this paper
• Thrombophilie et infarctus du myocarde

  2007cites this paper
• Inherited thrombophilia in arterial disease: a selective review.

  2007cites this paper
• Chronisch-arterielle Verschlusskrankheit der Beine im Stadium IIb-IV

  2006cites this paper
• Thrombophile Gerinnungsstörungen bei peripherer arterieller Verschlusskrankheit

  2006cites this paper
• Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.

  2005cites this paper
• Prothrombin 20210A Allele May Not Be an Independent Risk Factor for Myocardial Infarction

  2005cites this paper
• Thrombophilic risk factors for symptomatic peripheral arterial disease.

  2005cites this paper
• Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

  2005cites this paper
• The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case–control study

  2004cites this paper
• Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.

  2003influential citation
• Laboratory evaluation of hypercoagulability with venous or arterial thrombosis.

  2002cites this paper
• Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease

  2001cites this paper
• Hemostatic Risk Factors and Arterial Thrombotic Disease

  2001cites this paper
• The role of prothrombotic mutations in patients with Buerger's disease.

  2000cites this paper